close

Clinical Trials

1 2 3 4 5 209
Number of results: 4174

Excel print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2017-12-18 cariprazine bipolar depression 3 Gedeon Richter (Hungary) Allergan (Ireland) CNS diseases - Mental diseases
2017-12-18 HLA-A2 CAR lentiviral vector preclinical Txcell (France) Inflammatory diseases
2017-12-18 BION-1301 relapsed or refractory multiple myeloma 1-2 Aduro Biotech (USA - CA) Cancer - Oncology
2017-12-18 Qarziba®/Isqette® (APN311 - dinutuximab beta) neuroblastoma Apeiron Biologics (Austria) Cancer - Oncology
2017-12-16 SEL24 acute myeloid leukemia 1-2 Selvita (Poland) Cancer - Oncology
2017-12-15 fitusiran (SAR439774 - ALN-AT3) hemophilia A, hemophilia B with or without inhibitors 2 Alnylam Therapeutics (USA - MA), Sanofi (France) Rare diseases - Genetic diseases - Hematological diseases
2017-12-15 fitusiran (SAR439774 - ALN-AT3) hemophilia A and B with or without inhibitors 3 Alnylam Therapeutics (USA - MA), Sanofi (France) Rare diseases - Genetic diseases - Hematological diseases
2017-12-15 fitusiran (SAR439774 - ALN-AT3) hemophilia A and B with or without inhibitors 3 Alnylam Therapeutics (USA - MA), Sanofi (France) Rare diseases - Genetic diseases - Hematological diseases
2017-12-15 fitusiran (SAR439774 - ALN-AT3) hemophilia A and B with or without inhibitors 3 Alnylam Therapeutics (USA - MA), Sanofi (France) Rare diseases - Genetic diseases - Hematological diseases
2017-12-14 hemophilia Shire (UK - USA) Royal College of Surgeons Ireland (Ireland) Science Foundation Ireland (SFI) (Ireland) Irish Haemophilia Society (Ireland) Rare diseases - Genetic diseases - Hematological diseases
2017-12-14 PF-04965842 moderate-to-severe atopic dermatitis (AD) 3 Pfizer (USA - NY) Autoimmune diseases - Dermatological diseases
2017-12-13 REGN2810 - cemiplimab advanced cutaneous squamous cell carcinoma 2 Regeneron Pharmaceuticals (USA - NY) Sanofi (France) Cancer - Oncology
2017-12-13 Trumenba® - rLP2086 coadministered with routine meningococcal (groups A, C, Y and W) (MCV4) and tetanus, diphtheria and pertussis (Tdap) vaccines 3 Pfizer (USA - NY)
2017-12-12 UCART19 relapsed or refractory (R/R) CD19-positive B-cell acute lymphoblastic leukemia (B-ALL) 1 Cellectis (France) Servier (France) Pfizer (USA - NY) Cancer - Oncology
2017-12-12 TPIV200 prevention of cancer recurrence in women with triple-negative breast cancer (TNBC) who have completed first-line surgery and radiotherapy/chemotherapy 2 Tapimmune (USA - FL) Cancer - Oncology
2017-12-12 Tesomet® (tesofensine and metoprolol) type 2 diabetes 2a Saniona (Denmark) Metabolic diseases
2017-12-12 caplacizumab thrombotic thrombocytopenic purpura (TTP) 3 Ablynx (Belgium) Autoimmune diseases - Rare diseases
2017-12-12 UCART19 relapsed/refractory B acute lymphoblastic leukaemia (ALL) 1 Cellectis (France) Servier (France) Pfizer (USA - NY) Cancer - Oncology
2017-12-11 crizanlizumab (SEG101) sickle cell disease 2 Novartis (Switzerland) Cancer - Oncology
2017-12-11 SPK-9001 hemophilia B 1-2 Pfizer (USA - NY) Spark Therapeutics (USA - PA) Rare diseases - Genetic diseases - Hematological diseases